{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-143202","form_type":"8-K","ticker":"KLRS","cik":"0001754068","company_name":"Kalaris Therapeutics, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.590325+00:00","generated_at":"2026-05-19T01:36:35.807018+00:00","sec_items":["5.08","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Kalaris sets Aug 12, 2025 annual meeting; stockholder proposals due June 30","bullets":["2025 annual meeting scheduled for August 12, 2025; postponed from typical anniversary date.","Rule 14a-8 stockholder proposals must be received by June 30, 2025 to be included in proxy materials.","Director nominations under by-laws also due June 30, 2025, as meeting delayed over 60 days from prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-143202","json":"https://secwatch.observer/filing/0001193125-25-143202.json","markdown":"https://secwatch.observer/filing/0001193125-25-143202.md","text":"https://secwatch.observer/filing/0001193125-25-143202.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1754068/000119312525143202/0001193125-25-143202-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1754068/000119312525143202/d45802d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:36:35.807018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}